|Articles|September 15, 2002
- BioPharm International-09-01-2002
- Volume 15
- Issue 9
Attack Mounts on Pharmaceutical Prices
Author(s)Jill Wechsler
by Jill Wechsler. Pressure to enact an affordable Medicare drug benefit is driving legislation that threatens patent protections and boosts cheap imports.
Advertisement
Articles in this issue
about 23 years ago
Reexamining the Set It and Forget It Approachabout 23 years ago
Security in the Corporate Homelandabout 23 years ago
Integrating New Technology into Blood Plasma Fractionationabout 23 years ago
If a Tree Fell in the ForestNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
New Draft Guidance Highlights FDA Push Toward Human-Relevant Safety Models
2
Implementing Automation and Flexible Design for Allogeneic Manufacturing
3
Regulatory Uncertainty Surfaces as FDA Blames COVID Vaccines for 10 Child Deaths
4
Neurimmune and AstraZeneca Expand Efforts to Accelerate Fibril-Depleting Therapies
5
